Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.
ALNYLAM PHARMACEUTICALS, INC. net margin for the quarter ending 2026-06-30 was 12.74%, a change of 22.08% year-over-year.
ALNYLAM PHARMACEUTICALS, INC. net margin for the quarter ending 2025-12-31 was 10.17%, a change of 24.29% year-over-year.
ALNYLAM PHARMACEUTICALS, INC. net margin for the quarter ending 2025-09-30 was 20.10%, a change of 42.38% year-over-year.
ALNYLAM PHARMACEUTICALS, INC. net margin for the quarter ending 2025-06-30 was -9.34%, a change of -6.78% year-over-year.
ALNYLAM PHARMACEUTICALS, INC. net margin for fiscal 2025 was 8.45%, a change of 20.82% from fiscal 2024.
ALNYLAM PHARMACEUTICALS, INC. net margin for fiscal 2024 was -12.37%, a change of 11.71% from fiscal 2023.
ALNYLAM PHARMACEUTICALS, INC. net margin for fiscal 2023 was -24.08%, a change of 84.96% from fiscal 2022.
ALNYLAM PHARMACEUTICALS, INC. net margin for fiscal 2022 was -109.04%, a change of -8.02% from fiscal 2021.